Ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate
C24H21BrCl2N2O2 — CID 151354817
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate
Ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate (PubChem CID 151354817) has the molecular formula C24H21BrCl2N2O2 and a molecular weight of 520.25 g/mol. Its IUPAC name is ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate |
|---|---|
| PubChem CID | 151354817 |
| Molecular Formula | C24H21BrCl2N2O2 |
| Molecular Weight | 520.25 g/mol |
| Exact Mass | 518.02 |
| IUPAC Name | ethyl (7E)-7-[(4-bromophenyl)methylidene]-1-[(2,4-dichlorophenyl)methyl]-5,6-dihydro-4H-indazole-3-carboxylate |
| SMILES | CCOC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2c1CCC/C2=C\c1ccc(Br)cc1 |
| InChI | InChI=1S/C24H21BrCl2N2O2/c1-2-31-24(30)22-20-5-3-4-16(12-15-6-9-18(25)10-7-15)23(20)29(28-22)14-17-8-11-19(26)13-21(17)27/h6-13H,2-5,14H2,1H3/b16-12+ |
| InChIKey | ONGHIMQUZVZXDA-FOWTUZBSSA-N |
| XLogP | 7.05 |
| TPSA | 44.12 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.25 |
| LogP ≤ 5 | 7.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151354817 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.